Canary Capital Brings Injective to Nasdaq With New INJ Staked ETF

Canary Capital launched a Nasdaq-listed ETF tied to Injective’s INJ token that also incorporates staking rewards, giving traditional investors combined price exposure and yield on the asset. The fund marks one of the first U.S. exchange-traded products to pair a specialized layer-1 token with staking, extending the issuer’s lineup of single-asset crypto ETFs. The move matters because it tests whether investors want targeted blockchain exposure rather than broad crypto baskets, and whether staking-enhanced structures can attract flows in a crowded ETF market. Watch initial trading volume and assets under management in the first weeks, the staking yield net of fees the fund discloses, and whether rival issuers follow with staking-enabled single-token products.